Back

The cardioprotective effect of FFR-significant multivessel disease detected by cardiac magnetic resonance imaging in patients following ST-segment elevation myocardial infarction. Results from DANAMI3

2 September 2019 (10:05 - 10:55)
Organised by:
Congress Presentation Part of: Innovations in CMR for coronary artery disease Myocardial Disease ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Kathrine Ekstroem

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

6 More presentations in this session

Presentation thumbnail
Feasibility and prognostic value of vasodilator stress perfusion CMR in elderly patients > 75 years without known CAD
Doctor T. Pezel (Paris, FR)
Abstract Slides
Presentation thumbnail
Left ventricular thrombus formation after ST-elevation myocardial infarction: a prospective observational CMR study
Doctor M. Holzknecht (Innsbruck, AT)
Abstract Slides
Presentation thumbnail
Atrioventricular mechanical coupling and major adverse cardiac events in female patients following acute ST elevation myocardial infarction
Doctor S. Backhaus (Bad Nauheim, DE)
Abstract Slides
Presentation thumbnail
Association with coronary high-intensity plaque on T1-weighted magnetic resonance imaging and circulating levels of malondialdehyde-modified low-density lipoprotein
Doctor D. Hiraya (Tsukuba, JP)
Abstract Slides
Presentation thumbnail
Lymphatic insufficiency increases cardiac edema after myocardial infarction as assessed by novel magnetic resonance TRAFFn and T2 relaxation times
Mr E. Yla-Herttuala (Kuopio, FI)
Abstract

Access the full session

Session thumbnail
Innovations in CMR for coronary artery disease

The Event

Event poster

ESC Congress 2019

2 September 2019 10:05 CET
You may be interested in
thumbnail
Congress Session
Advanced imaging in heart failure
thumbnail
Congress Session
Ventricular arrhythmias and prevention of sudden cardiac death (1)
thumbnail
Webinar
The role of cardiac magnetic resonance for patients with ventricular arrhythmias and the prevention of sudden cardiac death in light of the 2022 ESC Guidelines

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources